European journal of gastroenterology & hepatology
-
Eur J Gastroenterol Hepatol · Jun 2021
Dynamics of liver stiffness-based risk prediction model during antiviral therapy in patients with chronic hepatitis B.
The liver stiffness-based risk prediction models predict hepatocellular carcinoma (HCC) development. We investigated the influence of antiviral therapy (AVT) on liver stiffness-based risk prediction model in patients with chronic hepatitis B (CHB). ⋯ The mREACH-B score was dynamically changed during AVT. Thus, repeated assessment of the mREACH-B score is required to predict the changing risk of HCC development in patients with CHB undergoing AVT.